(A) Splenocytes were stained with antibodies specific for CD21, CD23 and IgM, and subjected to FCM analysis. CD23− (A) and CD23+ (B) populations were gated separately and analyzed according to CD21 and IgM expression. Cell populations were defined using the following markers: T1 cells, CD23−IgMhiCD21−; T2 B cells, CD23+IgMhiCD21+; MZP cells, CD23+IgMhiCD21hi; MZ B cells, CD23−IgMhiCD21hi; and FO B cells, CD23+IgMloCD21lo. The numbers denote the percentages of cells in the indicated squares. Data are representative of five independent experiments. (B) The absolute numbers of splenic T1, T2 and MZP B cells were calculated from the FCM data in (A) and the total number of erythrocyte-depleted splenocytes. Data represent the mean±S.D. from five independent experiments.